Annual report

Period2022-01-01 → 2022-12-31

Filed2023-03-23

StandardJapan GAAP

ConsolidatedYes

Data checks17 of 17 passed

Amended by S100QG6E (2023-03-24).

Key figures · 100

Metric	Value	Period	Scope	Source row
Revenue	¥10.0bn	2022-01-01 → 2022-12-31	Cons.	Net sales
Operating income	¥2.0bn	2022-01-01 → 2022-12-31	Cons.	Operating income
Ordinary income	¥2.0bn	2022-01-01 → 2022-12-31	Cons.	Ordinary income
Profit before tax	¥2.1bn	2022-01-01 → 2022-12-31	Cons.	Income before income taxes
Net income (owners)	¥1.2bn	2022-01-01 → 2022-12-31	Cons.	Profit loss attributable to owners of parent
Net income	¥1.2bn	2022-01-01 → 2022-12-31	Cons.	Profit loss
Total assets	¥10.4bn	at 2022-12-31	Cons.	Assets
Total liabilities	¥1.9bn	at 2022-12-31	Cons.	Liabilities
Net assets / equity	¥8.5bn	at 2022-12-31	Cons.	Net assets
Net assets / equity	¥6.7bn	at 2021-12-31	Cons.	Net assets
Cash and deposits	¥6.3bn	at 2022-12-31	Cons.	Cash and deposits
Cash & equivalents	¥6.3bn	at 2022-12-31	Cons.	Cash and cash equivalents
Cash & equivalents	¥3.9bn	at 2021-12-31	Cons.	Cash and cash equivalents
Operating cash flow	¥1.6bn	2022-01-01 → 2022-12-31	Cons.	Net cash provided by used in operating activities
Investing cash flow	−¥47m	2022-01-01 → 2022-12-31	Cons.	Net cash provided by used in investment activities
Financing cash flow	¥628m	2022-01-01 → 2022-12-31	Cons.	Net cash provided by used in financing activities
EPS (basic)	¥30.2	2022-01-01 → 2022-12-31	Cons.	Basic earnings loss per share (5-year summary)
EPS (diluted)	¥29.77	2022-01-01 → 2022-12-31	Cons.	Diluted earnings per share (5-year summary)
Net assets per share	¥204.83	at 2022-12-31	Cons.	Net assets per share (5-year summary)
Equity ratio	77.6%	at 2022-12-31	Cons.	Equity to asset ratio (5-year summary)
ROE	14.6%	2022-01-01 → 2022-12-31	Cons.	Rate of return on equity (5-year summary)
Employees	122	at 2022-12-31	Cons.	Number of employees
Revenue	¥10.0bn	2022-01-01 → 2022-12-31	Standalone	Net sales
Revenue	¥8.3bn	2021-01-01 → 2021-12-31	Standalone	Net sales
Revenue	¥3.0bn	2020-01-01 → 2020-12-31^d	Standalone	Net sales (5-year summary)
Revenue	¥2.8bn	2019-01-01 → 2019-12-31^d	Standalone	Net sales (5-year summary)
Revenue	¥3.8bn	2018-01-01 → 2018-12-31^d	Standalone	Net sales (5-year summary)
Operating income	¥2.0bn	2022-01-01 → 2022-12-31	Standalone	Operating income
Operating income	¥1.0bn	2021-01-01 → 2021-12-31	Standalone	Operating income
Ordinary income	¥2.0bn	2022-01-01 → 2022-12-31	Standalone	Ordinary income
Ordinary income	¥1.0bn	2021-01-01 → 2021-12-31	Standalone	Ordinary income
Ordinary income	−¥4.6bn	2020-01-01 → 2020-12-31^d	Standalone	Ordinary income loss (5-year summary)
Ordinary income	−¥4.4bn	2019-01-01 → 2019-12-31^d	Standalone	Ordinary income loss (5-year summary)
Ordinary income	−¥2.7bn	2018-01-01 → 2018-12-31^d	Standalone	Ordinary income loss (5-year summary)
Profit before tax	¥2.1bn	2022-01-01 → 2022-12-31	Standalone	Income before income taxes
Profit before tax	¥1.0bn	2021-01-01 → 2021-12-31	Standalone	Income before income taxes
Net income	¥1.2bn	2022-01-01 → 2022-12-31	Standalone	Profit loss
Net income	¥2.0bn	2021-01-01 → 2021-12-31	Standalone	Profit loss
Net income	−¥4.1bn	2020-01-01 → 2020-12-31^d	Standalone	Net income loss (5-year summary)
Net income	−¥4.4bn	2019-01-01 → 2019-12-31^d	Standalone	Net income loss (5-year summary)
Net income	−¥2.8bn	2018-01-01 → 2018-12-31^d	Standalone	Net income loss (5-year summary)
Total assets	¥10.4bn	at 2022-12-31	Standalone	Assets
Total assets	¥8.5bn	at 2021-12-31	Standalone	Assets
Total assets	¥6.3bn	at 2020-12-31^d	Standalone	Total assets (5-year summary)
Total assets	¥5.3bn	at 2019-12-31^d	Standalone	Total assets (5-year summary)
Total assets	¥6.2bn	at 2018-12-31^d	Standalone	Total assets (5-year summary)
Total liabilities	¥1.9bn	at 2022-12-31	Standalone	Liabilities
Total liabilities	¥1.7bn	at 2021-12-31	Standalone	Liabilities
Net assets / equity	¥8.5bn	at 2022-12-31	Standalone	Net assets
Net assets / equity	¥6.7bn	at 2021-12-31	Standalone	Net assets
Net assets / equity	¥4.7bn	at 2020-12-31^d	Standalone	Net assets
Net assets / equity	¥4.4bn	at 2019-12-31^d	Standalone	Net assets (5-year summary)
Net assets / equity	¥4.9bn	at 2018-12-31^d	Standalone	Net assets (5-year summary)
Cash and deposits	¥6.3bn	at 2022-12-31	Standalone	Cash and deposits
Cash and deposits	¥3.9bn	at 2021-12-31	Standalone	Cash and deposits
Cash & equivalents	¥3.9bn	at 2021-12-31	Standalone	Cash and cash equivalents (5-year summary)
Cash & equivalents	¥3.8bn	at 2020-12-31^d	Standalone	Cash and cash equivalents (5-year summary)
Cash & equivalents	¥3.9bn	at 2019-12-31^d	Standalone	Cash and cash equivalents (5-year summary)
Cash & equivalents	¥4.8bn	at 2018-12-31^d	Standalone	Cash and cash equivalents (5-year summary)
Operating cash flow	¥140m	2021-01-01 → 2021-12-31	Standalone	Net cash provided by used in operating activities (5-year summary)
Operating cash flow	−¥4.1bn	2020-01-01 → 2020-12-31^d	Standalone	Net cash provided by used in operating activities (5-year summary)
Operating cash flow	−¥4.4bn	2019-01-01 → 2019-12-31^d	Standalone	Net cash provided by used in operating activities (5-year summary)
Operating cash flow	−¥2.3bn	2018-01-01 → 2018-12-31^d	Standalone	Net cash provided by used in operating activities (5-year summary)
Investing cash flow	−¥71m	2021-01-01 → 2021-12-31	Standalone	Net cash provided by used in investing activities (5-year summary)
Investing cash flow	−¥160m	2020-01-01 → 2020-12-31^d	Standalone	Net cash provided by used in investing activities (5-year summary)
Investing cash flow	−¥216m	2019-01-01 → 2019-12-31^d	Standalone	Net cash provided by used in investing activities (5-year summary)
Investing cash flow	−¥26m	2018-01-01 → 2018-12-31^d	Standalone	Net cash provided by used in investing activities (5-year summary)
Financing cash flow	−¥72m	2021-01-01 → 2021-12-31	Standalone	Net cash provided by used in financing activities (5-year summary)
Financing cash flow	¥4.2bn	2020-01-01 → 2020-12-31^d	Standalone	Net cash provided by used in financing activities (5-year summary)
Financing cash flow	¥3.7bn	2019-01-01 → 2019-12-31^d	Standalone	Net cash provided by used in financing activities (5-year summary)
Financing cash flow	¥4.3bn	2018-01-01 → 2018-12-31^d	Standalone	Net cash provided by used in financing activities (5-year summary)
EPS (basic)	¥30.37	2022-01-01 → 2022-12-31	Standalone	Basic earnings loss per share (5-year summary)
EPS (basic)	¥53.04	2021-01-01 → 2021-12-31	Standalone	Basic earnings loss per share (5-year summary)
EPS (basic)	¥-124.13	2020-01-01 → 2020-12-31^d	Standalone	Basic earnings loss per share (5-year summary)
EPS (basic)	¥-189.03	2019-01-01 → 2019-12-31^d	Standalone	Basic earnings loss per share (5-year summary)
EPS (basic)	¥-165.54	2018-01-01 → 2018-12-31^d	Standalone	Basic earnings loss per share (5-year summary)
EPS (diluted)	¥29.95	2022-01-01 → 2022-12-31	Standalone	Diluted earnings per share (5-year summary)
EPS (diluted)	¥52.32	2021-01-01 → 2021-12-31	Standalone	Diluted earnings per share (5-year summary)
Net assets per share	¥204.95	at 2022-12-31	Standalone	Net assets per share (5-year summary)
Net assets per share	¥162.26	at 2021-12-31	Standalone	Net assets per share (5-year summary)
Net assets per share	¥105.76	at 2020-12-31^d	Standalone	Net assets per share (5-year summary)
Net assets per share	¥143.07	at 2019-12-31^d	Standalone	Net assets per share (5-year summary)
Net assets per share	¥212.23	at 2018-12-31^d	Standalone	Net assets per share (5-year summary)
Equity ratio	77.8%	at 2022-12-31	Standalone	Equity to asset ratio (5-year summary)
Equity ratio	73.7%	at 2021-12-31	Standalone	Equity to asset ratio (5-year summary)
Equity ratio	64.3%	at 2020-12-31^d	Standalone	Equity to asset ratio (5-year summary)
Equity ratio	71.7%	at 2019-12-31^d	Standalone	Equity to asset ratio (5-year summary)
Equity ratio	70.1%	at 2018-12-31^d	Standalone	Equity to asset ratio (5-year summary)
ROE	16.6%	2022-01-01 → 2022-12-31	Standalone	Rate of return on equity (5-year summary)
ROE	39.6%	2021-01-01 → 2021-12-31	Standalone	Rate of return on equity (5-year summary)
Shares issued	39,603,606	at 2022-12-31	Standalone	Total number of issued shares (5-year summary)
Shares issued	38,457,206	at 2021-12-31	Standalone	Total number of issued shares (5-year summary)
Shares issued	38,202,956	at 2020-12-31^d	Standalone	Total number of issued shares (5-year summary)
Shares issued	26,437,681	at 2019-12-31^d	Standalone	Total number of issued shares (5-year summary)
Shares issued	83,398,924	at 2018-12-31^d	Standalone	Total number of issued shares (5-year summary)
Employees	118	at 2022-12-31	Standalone	Number of employees
Employees	141	at 2021-12-31	Standalone	Number of employees
Employees	127	at 2020-12-31^d	Standalone	Number of employees
Employees	107	at 2019-12-31^d	Standalone	Number of employees
Employees	90	at 2018-12-31^d	Standalone	Number of employees

Periods use the dates stated in the filing. ^d = earlier-year period dated by calendar; ^v = that date confirmed by the company's own earlier filing.

Segments · 1

Segment	Item	Period	Value
Research And Development Manufacturing And Sales Of Pharmaceuticals Etc And Related Businessreportable segment	employees	at 2022-12-31	122 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,061

Item	Context	Value	Unit
Net cash provided by used in operating activities (5-year summary)	Prior1YearDuration_NonConsolidatedMember	140042000	JPY
Net cash provided by used in operating activities (5-year summary)	CurrentYearDuration_NonConsolidatedMember	－	JPY
Net cash provided by used in investing activities (5-year summary)	Prior4YearDuration_NonConsolidatedMember	-26180000	JPY
Net cash provided by used in investing activities (5-year summary)	Prior3YearDuration_NonConsolidatedMember	-216462000	JPY
Net cash provided by used in investing activities (5-year summary)	Prior2YearDuration_NonConsolidatedMember	-160309000	JPY
Net cash provided by used in investing activities (5-year summary)	Prior1YearDuration_NonConsolidatedMember	-70849000	JPY
Net cash provided by used in investing activities (5-year summary)	CurrentYearDuration_NonConsolidatedMember	－	JPY
Net cash provided by used in financing activities (5-year summary)	Prior4YearDuration_NonConsolidatedMember	4272056000	JPY
Net cash provided by used in financing activities (5-year summary)	Prior3YearDuration_NonConsolidatedMember	3740045000	JPY
Net cash provided by used in financing activities (5-year summary)	Prior2YearDuration_NonConsolidatedMember	4222090000	JPY
Net cash provided by used in financing activities (5-year summary)	Prior1YearDuration_NonConsolidatedMember	-71922000	JPY
Net cash provided by used in financing activities (5-year summary)	CurrentYearDuration_NonConsolidatedMember	－	JPY
Cash and cash equivalents (5-year summary)	Prior4YearInstant_NonConsolidatedMember	4821355000	JPY
Cash and cash equivalents (5-year summary)	Prior3YearInstant_NonConsolidatedMember	3910830000	JPY
Cash and cash equivalents (5-year summary)	Prior2YearInstant_NonConsolidatedMember	3848626000	JPY
Cash and cash equivalents (5-year summary)	Prior1YearInstant_NonConsolidatedMember	3860106000	JPY
Cash and cash equivalents (5-year summary)	CurrentYearInstant_NonConsolidatedMember	－	JPY
Number of employees	Prior4YearInstant_NonConsolidatedMember	90
Number of employees	Prior3YearInstant_NonConsolidatedMember	107
Number of employees	Prior2YearInstant_NonConsolidatedMember	127
Number of employees	Prior1YearInstant_NonConsolidatedMember	141
Number of employees	CurrentYearInstant_NonConsolidatedMember	118
Average number of temporary workers	Prior4YearInstant_NonConsolidatedMember	16
Average number of temporary workers	Prior3YearInstant_NonConsolidatedMember	18
Average number of temporary workers	Prior2YearInstant_NonConsolidatedMember	41
Average number of temporary workers	Prior1YearInstant_NonConsolidatedMember	45
Average number of temporary workers	CurrentYearInstant_NonConsolidatedMember	28
Total shareholder return	Prior4YearInstant_NonConsolidatedMember	0.868
Total shareholder return	Prior3YearInstant_NonConsolidatedMember	0.693
Total shareholder return	Prior2YearInstant_NonConsolidatedMember	0.433
Total shareholder return	Prior1YearInstant_NonConsolidatedMember	1.307
Total shareholder return	CurrentYearInstant_NonConsolidatedMember	0.734
Total return on share price index	Prior4YearInstant_NonConsolidatedMember	0.840
Total return on share price index	Prior3YearInstant_NonConsolidatedMember	0.992
Total return on share price index	Prior2YearInstant_NonConsolidatedMember	1.066
Total return on share price index	Prior1YearInstant_NonConsolidatedMember	1.202
Total return on share price index	CurrentYearInstant_NonConsolidatedMember	1.172
Number of employees	CurrentYearInstant_jpcrp030000-asr_E24682-000ResearchAndDevelopmentManufacturingAndSalesOfPharmaceuticalsEtcAndRelatedBusinessReportableSegmentMember	122
Average number of temporary workers	CurrentYearInstant_jpcrp030000-asr_E24682-000ResearchAndDevelopmentManufacturingAndSalesOfPharmaceuticalsEtcAndRelatedBusinessReportableSegmentMember	30
Number of employees	CurrentYearInstant	122
Average number of temporary workers	CurrentYearInstant	30
Number of employees	CurrentYearInstant_NonConsolidatedMember	118
Average number of temporary workers	CurrentYearInstant_NonConsolidatedMember	28
Average age years information about reporting company information about employees	CurrentYearInstant_NonConsolidatedMember	52.1
Average length of service years information about reporting company information about employees	CurrentYearInstant_NonConsolidatedMember	4.7
Average annual salary information about reporting company information about employees	CurrentYearInstant_NonConsolidatedMember	12082000	JPY
Research and development expenses research and development activities	CurrentYearDuration	2554799000	JPY
Capital expenditures overview of capital expenditures etc	CurrentYearDuration	47559000	JPY
Number of issued shares as of fiscal year end issued shares total number of shares etc	FilingDateInstant_OrdinaryShareMember	39603606
Number of issued shares as of filing date issued shares total number of shares etc	FilingDateInstant_OrdinaryShareMember	39622681

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 17 of 17 passed

balance sheet identity	consolidated 2022-12-31	pass
balance sheet identity	non_consolidated 2021-12-31	pass rounding
balance sheet identity	non_consolidated 2022-12-31	pass
dei present		pass
period resolution		pass
statement vs summary · net assets	consolidated 2022-12-31	pass
statement vs summary · net assets	non_consolidated 2020-12-31	pass
statement vs summary · net assets	non_consolidated 2021-12-31	pass
statement vs summary · net assets	non_consolidated 2022-12-31	pass
statement vs summary · net income attributable to parent	consolidated 2022-01-01/2022-12-31	pass
statement vs summary · operating cash flow	consolidated 2022-01-01/2022-12-31	pass
statement vs summary · revenue	consolidated 2022-01-01/2022-12-31	pass
statement vs summary · revenue	non_consolidated 2021-01-01/2021-12-31	pass
statement vs summary · revenue	non_consolidated 2022-01-01/2022-12-31	pass
statement vs summary · total assets	consolidated 2022-12-31	pass
statement vs summary · total assets	non_consolidated 2021-12-31	pass
statement vs summary · total assets	non_consolidated 2022-12-31	pass